Meta Health Eyes 30% of Aios Bio Sciences Share Capital
Meta Health Eyes 30% of Aios Bio Sciences Share Capital
Aios Bios is a private company limited by shares incorporated in Singapore on 25 July 2022.It is part of Meta Health's efforts to grow the group's healthcare business
这是美特尔集团努力发展医疗业务的一部分
Meta Health Limited is eyeing to acquire 30% of the entire issued and paid-up share capital of Aios Bio Sciences from Davin Ng and other shareholders.
美特尔有限公司正计划从Davin Ng和其他股东手中收购Aios Bio Sciences全部已发行和已付资本的30%股份。
The transaction is part of Meta Health's efforts to grow the group's healthcare business and diversify its revenue streams by expanding into the complementary segment of the manufacturing and distribution of medical and surgical consumables.
这项交易是美特尔集团为扩展其医疗业务并通过扩展医疗和外科消耗品的制造和分销领域而多样化其营业收入流的努力的一部分。
Aios Bios is a private company limited by shares incorporated in Singapore on 25 July 2022.
Aios Bios是一家于2022年7月25日在新加坡注册成立的有限责任公司。
Based on the information extracted from the Accounting and Corporate Regulatory Authority, Ng is a director of the company and holds 33.3% of the entire issued and paid share capital.
根据从会计和公司监管局获取的信息，Ng是该公司的董事，持有公司全部已发行和已付的33.3%股本。
